查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829720

2025年全球胰岛素输送装置市场报告

Insulin Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，胰岛素给药装置市场规模强劲成长，从2024年的177.1亿美元增加至2025年的190.7亿美元，复合年增长率为7.7%。预测期间的成长可归因于胰岛素给药装置便捷易用的特性、优惠的报销政策、肥胖盛行率的上升、人口老化加剧以及胰岛素帮浦普及率的提高。

预计未来几年胰岛素给药装置市场规模将强劲成长，2029年将达到259.8亿美元，复合年增长率为8.0%。预测期内的增长可归因于糖尿病患者数量的增长、糖尿病治疗医疗支出的增加、持续血糖监测系统的兴起、患者对自动化胰岛素给药装置益处的认识不断提高以及人们对医疗保健的日益重视。预测期间的主要趋势包括胰岛素给药装置的技术进步、胰岛素给药装置与数位技术的整合、人工胰臟系统的发展、胰岛素给药技术的进步以及仿生技术的进步。

胰岛素输送装置是专为糖尿病患者註射胰岛素而设计的医疗器材。对于无法自然分泌足够胰岛素的患者，这类装置对于血糖值的控制至关重要。它们可以有效控制血糖值，并为胰岛素注射提供灵活性和便利性。

胰岛素给药装置的主要类型包括胰岛素注射器、胰岛素喷射注射器、笔式针头、可重复使用胰岛素笔、抛弃式胰岛素笔、胰岛素帮浦、体外帮浦、繫留帮浦和贴片帮浦。胰岛素注射器专为皮下注射胰岛素而设计，其特点是针头细而短，并带有清晰的剂量指示器，以确保激素给药的准确性。这些装置可用于治疗第1型和第2型糖尿病，可透过多种管道购买，包括医院药局、零售药局、线上销售以及糖尿病诊所和中心。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供胰岛素注射装置市场统计数据，包括全球市场规模、区域份额、胰岛素注射装置市场份额竞争对手、详细的胰岛素注射装置细分市场、市场趋势和商机，以及您在胰岛素注射装置行业取得成功所需的数据。本胰岛素注射装置市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年8.0%的预测成长率，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自新加坡和加拿大等主要地区的微流体晶片和蓝牙剂量追踪器征收关税直接影响美国，从而导致糖尿病管理方案减少，智慧胰岛素技术成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响可能会更加广泛。

糖尿病盛行率的不断上升预计将在未来几年推动胰岛素输送装置市场的成长。糖尿病是一种慢性疾病，其特征是由于胰臟分泌胰岛素不足或身体无法有效利用胰岛素而导致血糖值升高。糖尿病患者人数的增加主要是由于久坐不动的生活方式、不良饮食习惯和全球肥胖率上升等因素。胰岛素输送装置对于管理糖尿病至关重要，因为控制和方便地註射胰岛素可以有效控制血糖值、预防併发症并促进整体健康。例如，根据美国疾病管制与预防中心的数据，截至 2022 年 12 月，到 2060 年，美国20 岁以下 2 型糖尿病患者人数可能增加近 700%，达到 22 万人。此外，同期年轻人中第 1 型糖尿病的诊断率可能增加 65%。糖尿病盛行率的不断上升刺激了胰岛素给药装置市场的扩张。

胰岛素输送设备市场的主要企业正致力于开发创新产品，例如提供持续或可客製化胰岛素输送的胰岛素帮浦。胰岛素帮浦是可程式设计的医疗设备透过皮下导管持续或按需输送胰岛素。例如，2023年5月，美国医疗科技公司Beta Bionics的iLet ACE帮浦和iLet给药决策软体获得了美国食品药物管理局）的核准。 iLet仿生胰臟系统专为6岁及以上第1型糖尿病患者设计，将两种设备与相容的FDA核准的整合式连续血糖监测仪（iCGM）整合在一起。该系统采用自适应闭合迴路演算法驱动的自动胰岛素给药（AID）系统进行操作，仅需用户体重即可进行设置，无需额外的胰岛素给药参数。与传统的泵疗法不同，该系统无需手动设定调整，易于启动和管理。此外，iLet设备还引进了用餐提示功能。它透过将餐点分为小餐、中餐和大餐来简化用餐时的胰岛素剂量，并且演算法会随着时间的推移学习并适应个人的胰岛素需求。

2023年9月，美国医疗保健公司雅培（Abbott）收购了Bigfoot Biomedical，收购金额未揭露。此次收购将增强雅培在糖尿病照护领域的地位，扩大其享有盛誉的FreeStyle Libre动态血糖监测技术产品组合。此次收购符合雅培推动互联解决方案，实现个人化和精细化糖尿病管理的策略。 Bigfoot Biomedical是一家总部位于美国的胰岛素输送设备製造商。

胰岛素给药装置市场涵盖胰岛素输注器、胰岛素储液器、胰岛素帮浦配件和胰岛素笔芯的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球胰岛素输送装置：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球胰岛素输送装置市场：成长率分析
  • 全球胰岛素输送装置市场表现：规模与成长，2019-2024
  • 全球胰岛素注射装置市场预测：规模与成长，2024-2029年，2034年
  • 全球胰岛素输送装置：总目标市场（TAM）

第六章 市场细分

  • 全球胰岛素注射装置市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 胰岛素注射器
  • 胰岛素喷射注射器
  • 笔针
  • 可重复使用的胰岛素笔
  • 抛弃式胰岛素笔
  • 胰岛素帮浦
  • 外部或繫留泵
  • 贴片帮浦
  • 全球胰岛素输送装置市场（依疾病适应症、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 类型 1
  • 类型 2
  • 全球胰岛素给药装置市场（按分销管道）：2019-2024 年、2024-2029 年、2034 年实际及预测
  • 医院药房
  • 零售药局
  • 网上销售
  • 糖尿病诊所或中心
  • 全球胰岛素注射装置市场：按胰岛素注射器类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 标准胰岛素注射器
  • 固定或可调式针长胰岛素注射器
  • 全球胰岛素注射装置市场：按胰岛素喷射注射器类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 无针头胰岛素注射器
  • 高压胰岛素喷射注射器
  • 全球胰岛素注射装置市场：按笔针细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 短笔针
  • 长笔针
  • 全球胰岛素输送装置市场：可重复使用胰岛素笔细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 可重复使用的笔，附有可更换的墨盒
  • 可再填充胰岛素笔
  • 全球胰岛素输送装置市场：细分抛弃式胰岛素笔（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 一次性使用的抛弃式胰岛素笔
  • 一次性预填充胰岛素笔
  • 全球胰岛素输送装置市场：按胰岛素帮浦类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 传统胰岛素泵
  • 智慧胰岛素泵
  • 全球胰岛素输送装置市场：按类型细分：外部或系留帮浦、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 传统外部胰岛素泵
  • 无线繫绳帮浦
  • 全球胰岛素输送装置市场：贴片帮浦细分（按类型）、绩效及预测，2019-2024、2024-2029、2034
  • 贴片式胰岛素帮浦
  • 整合贴片帮浦

第七章 区域和国家分析

  • 全球胰岛素注射装置市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球胰岛素注射装置市场：国家、绩效及预测，2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 胰岛素输送装置市场：竞争格局
  • 胰岛素输送装置市场：公司简介
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Novo Nordisk A/S
  • Becton, Dickinson and Company
  • EOFlow Co. Ltd.
  • Insulet Corporation
  • Tandem Diabetes Care Inc.
  • Ypsomed Holding AG
  • Xeris Pharmaceuticals Inc.
  • Beta Bionics Inc.
  • Zealand Pharma AS
  • Bigfoot Biomedical Inc.
  • Emperra GmbH
  • Animas Corporation
  • Debiotech SA
  • CeQur Corporation
  • Aerami Therapeutics Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年胰岛素注射装置市场：提供新机会的国家
  • 2029年胰岛素输送装置市场：细分市场将带来新机会
  • 胰岛素注射装置市场2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30483u

Insulin delivery devices are medical tools designed to administer insulin to individuals with diabetes. These devices are essential for managing blood glucose levels in people who are unable to produce sufficient insulin naturally. They help control blood sugar levels effectively, offering flexibility and convenience in insulin administration.

The primary types of insulin delivery devices include insulin syringes, insulin jet injectors, pen needles, reusable insulin pens, disposable insulin pens, insulin pumps, external or tethered pumps, and patch pumps. Insulin syringes, in particular, are designed for the subcutaneous injection of insulin, featuring fine, short needles and clearly marked dosage indicators to ensure precise hormone delivery. These devices are used for both type 1 and type 2 diabetes and are available through various channels, including hospital pharmacies, retail pharmacies, online sales, and diabetes clinics or centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The insulin delivery devices market research report is one of a series of new reports from The Business Research Company that provides insulin delivery devices market statistics, including insulin delivery devices industry global market size, regional shares, competitors with a insulin delivery devices market share, detailed insulin delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the insulin delivery devices industry. This insulin delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The insulin delivery devices market size has grown strongly in recent years. It will grow from $17.71 billion in 2024 to $19.07 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to convenience and ease of use offered by insulin delivery devices, favorable reimbursement policies, increasing prevalence of obesity, growing aging population, increasing adoption of insulin pumps.

The insulin delivery devices market size is expected to see strong growth in the next few years. It will grow to $25.98 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growing prevalence of diabetic population, increasing healthcare expenditure on diabetes care, rise of continuous glucose monitoring systems, growing awareness among patients about benefits of automated insulin delivery devices, rising focus on healthcare. Major trends in the forecast period include technological advancements in insulin delivery devices, integration of digital technology with insulin delivery devices, development of artificial pancreas systems, advancements in insulin administration technology, bionic technology advancements.

The forecast of 8.0% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on microfluidic chips and Bluetooth-enabled dose trackers, sourced from key regions such as Singapore and Canada, which could lead to reduced diabetes management options and increased costs for smart insulin technology.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is expected to drive the growth of the insulin delivery device market in the coming years. Diabetes is a chronic condition characterized by elevated blood sugar levels due to either insufficient insulin production by the pancreas or the body's inability to effectively use insulin. The rise in diabetes cases is largely attributed to factors such as sedentary lifestyles, poor diets, and increasing obesity rates worldwide. Insulin delivery devices are essential for managing diabetes, as they allow individuals to control their blood sugar levels effectively by administering insulin in a controlled and convenient manner, thus preventing complications and promoting overall health. For example, according to the Centers for Disease Control and Prevention, a U.S.-based government agency, as of December 2022, the number of young people under 20 with type 2 diabetes in the United States could increase by nearly 700% by 2060, potentially reaching 220,000 individuals. Additionally, diagnoses of type 1 diabetes among young people could rise by as much as 65% over the same period. This growing prevalence of diabetes is fueling the expansion of the insulin delivery device market.

Leading companies in the insulin delivery device market are focusing on developing innovative products, such as insulin pumps, which provide continuous or customizable insulin delivery. Insulin pumps are programmable medical devices that deliver insulin continuously or on demand through a catheter placed under the skin. For instance, in May 2023, Beta Bionics, a U.S.-based medical technology company, received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system, designed for individuals aged six and older with type 1 diabetes, integrates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). This system operates using an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which only requires the user's body weight for setup and eliminates the need for additional insulin dosing parameters. Unlike traditional pump therapy, this system requires no manual adjustment of settings, making it easier to initiate and manage. Additionally, the iLet device introduces a meal announcement feature that simplifies mealtime insulin dosing by categorizing meals as small, medium, or large, with the algorithm learning and adapting to individual insulin needs over time.

In September 2023, Abbott, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by expanding its renowned FreeStyle Libre portfolio of continuous glucose monitoring technology. The move aligns with Abbott's strategy to advance connected solutions, aiming to personalize and refine diabetes management. Bigfoot Biomedical is a U.S.-based manufacturer of insulin delivery devices.

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

North America was the largest region in the insulin delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the insulin delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The insulin delivery devices market consists of sales of insulin infusion sets, insulin reservoirs, insulin pump accessories, and insulin cartridges. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Insulin Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on insulin delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for insulin delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The insulin delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Insulin Syringes; Insulin Jet Injectors; Pen Needles; Reusable Insulin Pens; Disposable Insulin Pens; Insulin Pumps; External Or Tethered Pumps; Patch Pumps
  • 2) By Disease Indication: Type 1; Type 2
  • 3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Sales; Diabetes Clinics Or Centers
  • Subsegments:
  • 1) By Insulin Syringes: Standard Insulin Syringes; Insulin Syringes With Fixed Or Adjustable Needle Length
  • 2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors; High-Pressure Insulin Jet Injectors
  • 3) By Pen Needles: Short Pen Needles; Long Pen Needles
  • 4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges; Refillable Insulin Pens
  • 5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens; Pre-Filled Disposable Insulin Pens
  • 6) By Insulin Pumps: Traditional Insulin Pumps; Smart Insulin Pumps
  • 7) By External Or Tethered Pumps: Traditional External Insulin Pumps; Wireless Tethered Pumps
  • 8) By Patch Pumps: Patch Insulin Pumps; Integrated Patch Pumps
  • Companies Mentioned: Sanofi SA; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Eli Lilly and Company; Novo Nordisk A/S; Becton, Dickinson and Company; EOFlow Co. Ltd.; Insulet Corporation; Tandem Diabetes Care Inc.; Ypsomed Holding AG; Xeris Pharmaceuticals Inc.; Beta Bionics Inc.; Zealand Pharma AS; Bigfoot Biomedical Inc.; Emperra GmbH; Animas Corporation; Debiotech SA; CeQur Corporation; Aerami Therapeutics Inc.; Alshifa Medical Group; AMF Medical SA; Andain Inc.; Avecho Biotechnology Ltd.; Apex Medical Devices
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Insulin Delivery Devices Market Characteristics

3. Insulin Delivery Devices Market Trends And Strategies

4. Insulin Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Insulin Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Insulin Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Insulin Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Insulin Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Insulin Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Insulin Delivery Devices Total Addressable Market (TAM)

6. Insulin Delivery Devices Market Segmentation

  • 6.1. Global Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Syringes
  • Insulin Jet Injectors
  • Pen Needles
  • Reusable Insulin Pens
  • Disposable Insulin Pens
  • Insulin Pumps
  • External Or Tethered Pumps
  • Patch Pumps
  • 6.2. Global Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type 1
  • Type 2
  • 6.3. Global Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales
  • Diabetes Clinics Or Centres
  • 6.4. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Insulin Syringes
  • Insulin Syringes With Fixed Or Adjustable Needle Length
  • 6.5. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Jet Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Needle-Free Insulin Jet Injectors
  • High-Pressure Insulin Jet Injectors
  • 6.6. Global Insulin Delivery Devices Market, Sub-Segmentation Of Pen Needles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Short Pen Needles
  • Long Pen Needles
  • 6.7. Global Insulin Delivery Devices Market, Sub-Segmentation Of Reusable Insulin Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reusable Pens With Replaceable Cartridges
  • Refillable Insulin Pens
  • 6.8. Global Insulin Delivery Devices Market, Sub-Segmentation Of Disposable Insulin Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Disposable Insulin Pens
  • Pre-Filled Disposable Insulin Pens
  • 6.9. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Insulin Pumps
  • Smart Insulin Pumps
  • 6.10. Global Insulin Delivery Devices Market, Sub-Segmentation Of External Or Tethered Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional External Insulin Pumps
  • Wireless Tethered Pumps
  • 6.11. Global Insulin Delivery Devices Market, Sub-Segmentation Of Patch Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patch Insulin Pumps
  • Integrated Patch Pumps

7. Insulin Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Insulin Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Insulin Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Insulin Delivery Devices Market

  • 8.1. Asia-Pacific Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Insulin Delivery Devices Market

  • 9.1. China Insulin Delivery Devices Market Overview
  • 9.2. China Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Insulin Delivery Devices Market

  • 10.1. India Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Insulin Delivery Devices Market

  • 11.1. Japan Insulin Delivery Devices Market Overview
  • 11.2. Japan Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Insulin Delivery Devices Market

  • 12.1. Australia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Insulin Delivery Devices Market

  • 13.1. Indonesia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Insulin Delivery Devices Market

  • 14.1. South Korea Insulin Delivery Devices Market Overview
  • 14.2. South Korea Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Insulin Delivery Devices Market

  • 15.1. Western Europe Insulin Delivery Devices Market Overview
  • 15.2. Western Europe Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Insulin Delivery Devices Market

  • 16.1. UK Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Insulin Delivery Devices Market

  • 17.1. Germany Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Insulin Delivery Devices Market

  • 18.1. France Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Insulin Delivery Devices Market

  • 19.1. Italy Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Insulin Delivery Devices Market

  • 20.1. Spain Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Insulin Delivery Devices Market

  • 21.1. Eastern Europe Insulin Delivery Devices Market Overview
  • 21.2. Eastern Europe Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Insulin Delivery Devices Market

  • 22.1. Russia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Insulin Delivery Devices Market

  • 23.1. North America Insulin Delivery Devices Market Overview
  • 23.2. North America Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Insulin Delivery Devices Market

  • 24.1. USA Insulin Delivery Devices Market Overview
  • 24.2. USA Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Insulin Delivery Devices Market

  • 25.1. Canada Insulin Delivery Devices Market Overview
  • 25.2. Canada Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Insulin Delivery Devices Market

  • 26.1. South America Insulin Delivery Devices Market Overview
  • 26.2. South America Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Insulin Delivery Devices Market

  • 27.1. Brazil Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Insulin Delivery Devices Market

  • 28.1. Middle East Insulin Delivery Devices Market Overview
  • 28.2. Middle East Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Insulin Delivery Devices Market

  • 29.1. Africa Insulin Delivery Devices Market Overview
  • 29.2. Africa Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Insulin Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Insulin Delivery Devices Market Competitive Landscape
  • 30.2. Insulin Delivery Devices Market Company Profiles
    • 30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Insulin Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Novo Nordisk A/S
  • 31.2. Becton, Dickinson and Company
  • 31.3. EOFlow Co. Ltd.
  • 31.4. Insulet Corporation
  • 31.5. Tandem Diabetes Care Inc.
  • 31.6. Ypsomed Holding AG
  • 31.7. Xeris Pharmaceuticals Inc.
  • 31.8. Beta Bionics Inc.
  • 31.9. Zealand Pharma AS
  • 31.10. Bigfoot Biomedical Inc.
  • 31.11. Emperra GmbH
  • 31.12. Animas Corporation
  • 31.13. Debiotech SA
  • 31.14. CeQur Corporation
  • 31.15. Aerami Therapeutics Inc.

32. Global Insulin Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Insulin Delivery Devices Market

34. Recent Developments In The Insulin Delivery Devices Market

35. Insulin Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Insulin Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Insulin Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Insulin Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer